HOME >> BIOLOGY >> NEWS
Small business at NJIT's business incubator takes two awards

This week, the company participated in the "Bio-Life-Tech Conference" in Baltimore and received an award for the company most likely to receive funding.

"We are happy to receive encouragement from our peers that our business plan and technology have merit," said Urovalve, Inc. President and Chief Executive Officer Harvey D. Homan, PhD.

"We hope this kind of attention can increase our odds for future funding and support from the business community."

Urovalve, Inc. is a fledgling enterprise that holds patents on a device which can be implanted through the urethra into the bladder via a simple procedure that does not require surgery. The device contains a metal valve which opens whenever the user wants and is activated by a pocket-sized magnetic wand the user carries.

Urovalve's device will improve the quality of life for men who cannot urinate due to nerve damage, disease or physical problems that affect the urethra. "About 4.5 million men in the U.S. are believed to suffer from these problems," said Homan. For more information about Urovalve, please visit: http://www.urovalve.com


'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
18-Oct-2004


Page: 1

Related biology news :

1. Small molecules may explain psoriasis
2. Small, self-controlled planes combine plant pathology and engineering
3. Small-scale agricultural changes may help eradicate widespread disease
4. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
5. Small molecule derived from Rb2/p130 could act as cancer therapeutic
6. Small molecule offers big hope against cancer
7. Small, smaller, smallest -- The plight of the vaquita
8. Small-scale logging leads to clear-cutting in Brazilian Amazon
9. Small, but mighty
10. Small molecule interactions were central to the origin of life
11. Smallest Triceratops skull ever found provides clues to dinosaurs growth

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Small business NJIT business incubator takes two awards

(Date:5/17/2013)... AGA Research Foundation announced a new grant that intends ... microbiota, one of today,s most exciting areas of science, ... Research Awards Panel selected Andrew T. Chan, MD, MPH ... Medical School, Boston, as the 2013 AGA-Elsevier Gut Microbiome ... of funding, commencing in July 2013, to test the ...
(Date:5/17/2013)... investigating the interaction of a group of proteins in ... have identified a new target that could increase cell ... University,s School of Biochemistry and published in the ... could eventually lead to new therapies for stroke and ... work by the team which identified a protein, known ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2SUMO wrestling cells reveal new protective mechanism target for stroke 2
(Date:5/17/2013)... immune system identifies the transplanted organ as foreign tissue ... cells, the immune cells that mediate rejection, must first ... to migrate to the transplanted organ. In this issue ... Lakkis and colleagues at the University of Pittsburgh used ... is not required for migration. Instead, these cells must ...
(Date:5/17/2013)... May 17, 2013 The new Public-Private ... at the association’s recent annual meeting drew praise ... Vice-President Neelie Kroes, who called the action “a huge ... a stimulant to European innovation.” , The Board of ... the new Photonics PPP at its 29 April meeting ...
(Date:5/17/2013)... PALO ALTO, Calif. , May 17, 2013 ... that it has achieved 50% enrollment of the ... trial to evaluate the safety and preliminary efficacy ... Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To ... Effect (SAE) reported. The Phase I ...
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
Cached News: